Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVSEF exchanges : Nasdaq save search
Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published: 2024-04-17 (Crawled : 10:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.26%
H: 0.03%
C: -1.55%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: 0.87%
H: 0.16%
C: -0.59%
RGNX | $15.775 -2.08% 340K
|
Health Technology
|
| O: -1.43%
H: 2.27%
C: -3.18%
global dna market
Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
Published: 2024-04-17 (Crawled : 06:00) - globenewswire.com
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: 0.87%
H: 0.16%
C: -0.59%
kesimpta sclerosis novartis show benefits
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: -1.24%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.19%
H: 0.52%
C: -0.17%
VRNA | $15.67 -2.67% 390K
|
Health Technology
|
| O: 1.65%
H: 2.43%
C: 0.87%
reach treatment research market
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
REGN | $893.67 -0.04% 230K
|
Health Technology
|
| O: -1.94%
H: 0.43%
C: -0.34%
OCUL | News | $5.22 -10.92% -12.26% 9.1M
|
Health Technology
|
| O: -1.03%
H: 3.66%
C: 1.7%
ocular key leaders
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.75%
H: 0.85%
C: 0.85%
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: -2.52%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.19%
H: 0.52%
C: -0.17%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: -0.1%
H: 0.13%
C: -1.08%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.32%
H: 0.96%
C: 0.22%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -2.13%
H: 0.0%
C: 0.0%
BMRN S | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.64%
H: 0.45%
C: -0.04%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
set therapeutics market
New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published: 2024-04-15 (Crawled : 18:00) - globenewswire.com
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
fabhalta nephropathy for novartis show
Novartis tender offer for MorphoSys AG commences
Published: 2024-04-11 (Crawled : 09:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.32%
H: 0.48%
C: -0.17%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: 0.32%
H: 0.04%
C: -0.56%
MOR | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: -0.39%
for novartis
Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published: 2024-04-10 (Crawled : 09:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -0.29%
H: 0.0%
C: -1.97%
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.6%
H: 1.03%
C: 0.52%
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -2.01%
H: 0.0%
C: 0.0%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: -1.16%
H: 0.0%
C: 0.0%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
JAZZ | $109.87 0.55% 570K
|
Health Technology
|
| O: -1.71%
H: 0.57%
C: 0.37%
disorders system set market
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: -3.43%
H: 6.21%
C: 6.21%
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.25%
H: 1.1%
C: -0.17%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: -0.05%
H: 0.43%
C: -0.27%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.08%
H: 0.04%
C: -0.35%
BHC | $8.63 0.35% 2.1M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -7.27%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.77%
H: 1.63%
C: 0.35%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.18%
H: 0.3%
C: 0.19%
eczema dermatitis set therapeutics market
New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
Published: 2024-04-06 (Crawled : 20:20) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.285 1.85% 1.6M
|
Health Technology
| Email alert
Add to watchlist
leqvio novartis therapy show
Positron Emission Tomography Market size is set to grow by USD 725.97 mn from 2024-2028,increasing prevalence of chronic conditions worldwide boost the market- Technavio
Published: 2024-04-03 (Crawled : 06:00) - prnewswire.com
CAJPY | News | $28.42 -0.41% 29K
|
n/a
|
| O: -0.3%
H: 0.54%
C: 0.54%
CAJFF | News | $29.0664 -28.15% 760
|
Electronic Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.86%
H: 0.17%
C: 0.17%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: 0.04%
H: 0.46%
C: -0.08%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: 1.0%
H: 0.0%
C: 0.0%
worldwide set market
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
NAMS | $19.98 2.78% 2.7% 140K
|
n/a
|
| O: 6.23%
H: 2.77%
C: -10.21%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: 0.47%
H: 0.23%
C: -0.99%
pharma business
Carisma Therapeutics Announces Changes to its Board of Directors
Published: 2024-04-01 (Crawled : 11:00) - prnewswire.com
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: 0.47%
H: 0.23%
C: -0.99%
CRIS | $14.59 -4.14% 9.6K
|
Health Technology
|
| O: 0.7%
H: 16.87%
C: 16.87%
therapeutics
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
| Email alert
Add to watchlist
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.385 2.19% 3M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.285 1.85% 1.6M
|
Health Technology
| Email alert
Add to watchlist
GNMSF | $290.38 3.83% 220
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
research global leukemia therapeutics market
LASIK Surgery Market size to record USD 1.24 bn growth from 2024-2028, Increasing medical tourism for LASIK surgery is one of the key market trends, Technavio
Published: 2024-03-28 (Crawled : 22:00) - prnewswire.com
NVS | $94.285 1.85% 1.6M
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.4 2.02% 6.4M
|
Health Technology
| Email alert
Add to watchlist
ALC | $79.55 1.38% -0.25% 1.1M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
one key medical growth market
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Published: 2024-03-28 (Crawled : 19:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.285 1.85% 1.6M
|
Health Technology
| Email alert
Add to watchlist
AVEO | $15.0 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
AUTL | $4.5 -6.25% 1.3M
|
Health Technology
| Email alert
Add to watchlist
medical
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published: 2024-03-28 (Crawled : 15:30) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
JNJ | News | $147.895 1.48% 5.8M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.02%
H: 0.51%
C: -0.3%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.26%
H: 2.03%
C: 1.57%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
antibody research global
Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.89%
H: 0.78%
C: 0.78%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.02%
H: 0.51%
C: -0.3%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.26%
H: 2.03%
C: 1.57%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.36%
H: 0.72%
C: 0.61%
ABT | News | $107.4 2.02% 6.4M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.12%
H: 0.25%
C: -0.63%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
abbvie set canada key market
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
Published: 2024-03-27 (Crawled : 20:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
ERAS | $1.74 -2.79% 380K
|
|
| O: 17.48%
H: 6.94%
C: -14.88%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
business year financial results
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
CRBU | $3.87 -1.02% -1.03% 1.7M
|
Health Technology
|
| O: 1.58%
H: 0.58%
C: -0.39%
NVS | $94.285 1.85% 1.6M
|
Health Technology
|
| O: 0.24%
H: 0.42%
C: 0.4%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.49%
H: 0.84%
C: -0.07%
TGTX | News | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: 0.71%
H: 0.39%
C: 0.13%
DTIL | $9.75 -9.05% -9.95% 170K
|
Health Technology
|
| O: 0.39%
H: 4.22%
C: 1.41%
precision business year update financial results
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.305 226.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
ASNS | $0.828 21.75% 17.86% 18K
|
UONE | $2.36 19.8% 16.53% 75K
|
Consumer Services
RWOD | $9.54 19.3% 16.18% 6.1M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.